Trial
NCT01957410
A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Janssen Research & Development, LLC
Collaborators
—
Condition
Major Depressive Disorder
Intervention
Ketamine
Why stopped
Clinical Team decision to terminate the study after the results from Cohort 1 did not support conducting Cohort 2.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-27